About Us BioXplor was established in 2017 and has built a highly experienced and multidisciplinary team of experts in computational sciences, biomedical sciences, drug discovery and clinical development. The company is backed by leading startup accelerators including UC Berkeley SkyDeck, Merck, Creative Destruction Labs, European Institute of Technology and Innovation (EIT Health) and European Innovation Council (EIC / Horizon 2020). BioXplor's investors include UC Berkeley SkyDeck Fund, Enterprise Ireland and IronFire Ventures. Our clients include top tier pharmaceutical companies like Novartis, Amgen, and Merck. Meet Our Managment Team and Advisory Board


SlideMark Rogers, MSc Co-Founder & CEO Co-Founder & COO Co-Founder & CTO Anna O'Leary, BA Pavel Kartasev, MEng, MSc Head of Machine Learning John Conway, MSc Advisor Advisor Advisor David Kwon, MD, PhD, MBA Prof. Jody J. Haigh, PhD Bill Allison Clinical Development Director Pharmacology and Therapeutics CTO at UC Berkeley